Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.
about
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraThe bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1Neuropsychological sequelae of haemolytic uraemic syndrome. Investigators of the HUS Cognitive Study.Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan.Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human seraIncreased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndromeSequelae of haemolytic uraemic syndrome.Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome.Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.Timing and utility of ultrasound in diarrhea-associated hemolytic uremic syndrome: 7-year experience of a large tertiary care hospital.A case of hemolytic uremic syndrome preceded by intussusception.Characteristics of children with sporadic hemolytic uremic syndrome in a single Northern California center.Myocarditis and haemolytic uraemic syndrome.Diarrhea-associated hemolytic uremic syndrome.A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators.Diarrhoea in close contacts as a risk factor for childhood haemolytic uraemic syndrome. The CPKDRC co-investigatorsThe role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study.A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California. A mandate for improved surveillance.Haemolytic-uraemic syndrome in the Hunter: public health implications.Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coliGenomic comparisons and Shiga toxin production among Escherichia coli O157:H7 isolates from a day care center outbreak and sporadic cases in southeastern WisconsinThrombotic thrombocytopenic purpura-hemolytic uremic syndrome: diagnosis and management.Hemolytic uremic syndrome: Events of the past decade.Enteric and foodborne disease in children: A review of the influence of food- and environment-related risk factors.Cattle lack vascular receptors for Escherichia coli O157:H7 Shiga toxinsAge-Related Changes in Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR1) and Receptor 2 (sVEGFR2) in Healthy Japanese SubjectsEscherichia coli O157:H7, other verotoxin-producing E coli and the hemolytic uremic syndrome in childhood.Diarrhea-associated hemolytic uremic syndrome in southern Alberta: A long-term single-centre experience.Hemolytic-uremic syndrome in asir region.Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.Screening for Escherichia coli O157:H7--a nationwide survey of clinical laboratories.Age-Related Changes of Serum Soluble Interleukin 9 Receptor (sIL-9Rα) in Healthy SubjectsDetermination of soluble tumor necrosis factor-α receptor type I (TNFRI) and II (TNFRII) in the urine of healthy Japanese subjects.Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits.FTIR nanobiosensors for Escherichia coli detection.
P2860
Q24241470-411C3F00-1E5B-4806-A40A-DF30DC8B0FF0Q24563989-4FF408EE-07A4-448D-9069-2DCCF86FD947Q33328791-90A9F228-CB83-4925-A657-A51AA559B4D4Q33331823-78843C4B-C4FA-4309-B5C8-97D1AF226CEDQ33335748-30FF374A-477C-4209-9ECF-1868A118AE23Q33335950-F9D32FBB-9959-44EE-810E-6F69DD600844Q33337454-050330FF-D0B6-4D9C-890D-11E07D2725A8Q33338235-AFD35019-E787-4658-92BC-A8C729EBC02BQ33338331-C0676867-9D57-4CEE-9E2F-4D81A20FEE71Q33342197-1CBE1C90-0FF4-43EB-8B77-46BCA8733E56Q33361289-C072F927-CBB9-489A-8CEB-03B083759DA4Q33364401-FE46728D-F697-4C49-9387-6DD7E372BB34Q33379319-5F08C489-7533-4BE8-B41D-B6DA74EE2973Q33387842-1463CE63-73F9-4A41-AF02-6756EF736354Q33396153-AB88F7DB-74ED-4E84-A6B9-CFDA7431D974Q33398432-3919ADC4-89AA-48C4-BC6A-F244E150F44AQ33489463-A4F9DA6F-662B-4C1E-9A4F-CD27F6A767A6Q33492981-F008B2EE-8D3A-49FB-BCFC-2930FD5055DDQ33494314-B7568A29-B9B9-419A-92A2-41C27395C526Q33494317-7608FCA8-82DE-44BE-A8E6-C3EA92EAB4A7Q33494653-BAFF1B7E-8C78-4337-9AE3-C9BF3A5C6514Q33497189-7E6E099B-DAD7-4E60-A37E-A349EC5DA877Q33498155-83EDB9ED-1BE1-4C7D-A487-D24B21EECA9EQ33498518-560B04A2-8A52-42A3-8451-0F0CE1ECABF8Q33500218-3048B3C0-DC05-4052-A1F4-4AF74E2448C5Q33501947-B78C07A7-B19F-4B7E-BADE-BC67D1F36403Q33504456-7E9508B0-9141-4F56-BA55-F91630E4817BQ33559388-BDC1A299-2EDD-4CFC-8A78-A94F86F7E67CQ33582704-76B6E8C3-9093-456E-8265-7BD55B72505DQ33916632-7A52B478-3111-47CD-B517-E6E63640FE7CQ35747105-8F9F6AC0-7210-4092-AD8E-614671B893A3Q35816742-F3696FE7-CA8B-4D79-A7BA-43B7D84D2D17Q35893773-2F027E63-92C5-4CE3-A0DF-0734ADE96A86Q36219162-5BF809AF-6CDC-4C5C-8B9F-860E7B76B3A2Q36521591-CD14A0FF-4074-4113-A81D-240AD9E7A2BAQ36526685-5DB5FA83-D1A8-4200-80E3-6DA662F9942FQ39341582-45F8F12B-81DE-4473-9DD1-5E3F56A4B972Q39773693-5EE0CBFE-88E2-4337-A276-FCF279E4124BQ39830255-6587A141-D779-4389-8C6A-5901F16F7DB5Q41998347-4C8A5F85-923C-4553-9DE4-468CD17CB52F
P2860
Epidemiology of hemolytic-uremic syndrome in Canadian children from 1986 to 1988. The Canadian Pediatric Kidney Disease Reference Centre.
description
1991 nî lūn-bûn
@nan
1991 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@ast
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@en
type
label
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@ast
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@en
prefLabel
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@ast
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@en
P2093
P1476
Epidemiology of hemolytic-urem ...... dney Disease Reference Centre.
@en
P2093
P304
P356
10.1016/S0022-3476(05)80730-9
P407
P577
1991-08-01T00:00:00Z